estrone has been researched along with Hemorrhage, Uterine in 38 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg medroxyprogesterone acetate (MPA) on GnRH agonists (GnRH-a) treatment in Japanese women with symptomatic endometriosis." | 9.09 | Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. ( Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T, 2001) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 7.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| "5 mg medroxyprogesterone acetate (MPA) on GnRH agonists (GnRH-a) treatment in Japanese women with symptomatic endometriosis." | 5.09 | Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. ( Aono, T; Irahara, M; Kamada, M; Kinoshita, H; Kiyokawa, M; Tezuka, M; Uemura, H; Yamada, M; Yasui, T, 2001) |
| "Plasma androstenedione (A) levels and plasma oestrone (E1) levels were measured by radioimmunoassay in a total of 135 healthy women (the control group), around the menopause." | 3.66 | Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium. ( Battaglia, F; Mango, D; Montemurro, A; Scirpa, P; Scirpa, S, 1982) |
| "However, vaginal bleeding complicating this therapy is among the leading causes for its early discontinuation." | 2.71 | Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms. ( Ben-Chetrit, A; Gelber, H; Hochner-Celnikier, D; Lindenberg, T; Shimonovitz, S; Spitz, IM; Zacut, D, 2005) |
| "Any vaginal bleeding was recorded by patients in a daily diary, and endometrial biopsies were performed at entry into the study and at 3, 12, and 24 months." | 2.69 | Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group. ( Baber, R; Nand, SL; O'Connor, V; Webster, MA, 1998) |
| "This pilot study was conducted to establish the optimum oral dosage of medroxyprogesterone acetate (Provera) given daily in combination with a fixed dose of piperazine oestrone sulphate (Ogen), as hormone replacement therapy." | 2.68 | Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes. ( Nand, SL; Webster, MA; Wren, BG, 1995) |
| "The ethinyl estradiol advantage was marginal, however." | 2.68 | Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Developmen ( Affandi, B; Belsey, EM; d'Arcangues, C; Dusitsin, N; Hadisaputra, W; Kazi, A; Kirwat, O; Koetsawang, S; Noonan, E; Olayinka, I; Pinol, A; Piya-Anant, M; Ramos, RM; Rocca, M; Sadek, W; Said, S; Sethavanich, S, 1996) |
| "The prognosis of threatened abortion can be made by a urinary PDG/C ratio but not by an E1C/C ratio." | 1.27 | Urinary pregnandiol-3-glucuronide and estrone conjugates to creatinine ratios in early pregnancies complicated by vaginal bleeding. ( Davidson, BJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (65.79) | 18.7374 |
| 1990's | 7 (18.42) | 18.2507 |
| 2000's | 6 (15.79) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZONDEK, B | 1 |
| ROZIN, S | 1 |
| Yildirim, M | 1 |
| Oktem, M | 1 |
| Dilek, TU | 1 |
| RAMOS, AV | 1 |
| PEANO, M | 1 |
| COUTINHO, S | 1 |
| MARCONDES, N | 1 |
| MELIN, A | 1 |
| TOJO, N | 1 |
| ZOLCINSKI, A | 1 |
| ROBACZYNSKI, J | 1 |
| HAEHNEL, R | 1 |
| MARTIN, JD | 1 |
| PLUNKETT, ER | 1 |
| Raynaud, JP | 1 |
| Lévrier, M | 1 |
| Calaf, J | 1 |
| Laur, C | 1 |
| Pélissier, C | 1 |
| Ben-Chetrit, A | 1 |
| Hochner-Celnikier, D | 1 |
| Lindenberg, T | 1 |
| Zacut, D | 1 |
| Shimonovitz, S | 1 |
| Gelber, H | 1 |
| Spitz, IM | 1 |
| Goldzieher, JW | 1 |
| Fariss, B | 1 |
| Jalůvka, V | 1 |
| Kratzsch, E | 1 |
| von Holst, T | 1 |
| Klinga, K | 1 |
| Runnebaum, B | 1 |
| Scirpa, P | 1 |
| Mango, D | 1 |
| Battaglia, F | 1 |
| Scirpa, S | 1 |
| Montemurro, A | 1 |
| Yasui, T | 2 |
| Uemura, H | 2 |
| Yoneda, N | 1 |
| Irahara, M | 2 |
| Aono, T | 2 |
| Sunahara, S | 1 |
| Hata, K | 1 |
| Nand, SL | 2 |
| Webster, MA | 2 |
| Wren, BG | 1 |
| AinMelk, Y | 1 |
| Said, S | 1 |
| Sadek, W | 1 |
| Rocca, M | 1 |
| Koetsawang, S | 1 |
| Kirwat, O | 1 |
| Piya-Anant, M | 1 |
| Dusitsin, N | 1 |
| Sethavanich, S | 1 |
| Affandi, B | 1 |
| Hadisaputra, W | 1 |
| Kazi, A | 1 |
| Ramos, RM | 1 |
| d'Arcangues, C | 1 |
| Belsey, EM | 1 |
| Noonan, E | 1 |
| Olayinka, I | 1 |
| Pinol, A | 1 |
| Ross, D | 1 |
| Cooper, AJ | 1 |
| Pryse-Davies, J | 1 |
| Bergeron, C | 1 |
| Collins, WP | 1 |
| Whitehead, MI | 1 |
| Hirvonen, E | 1 |
| Cacciatore, B | 1 |
| Wahlström, T | 1 |
| Rita, H | 1 |
| Wilén-Rosenqvist, G | 1 |
| Baber, R | 1 |
| O'Connor, V | 1 |
| Byrjalsen, I | 1 |
| Alexandersen, P | 1 |
| Christiansen, C | 1 |
| Kinoshita, H | 1 |
| Yamada, M | 1 |
| Tezuka, M | 1 |
| Kiyokawa, M | 1 |
| Kamada, M | 1 |
| Rebar, RW | 1 |
| Trabal, J | 1 |
| Mortola, J | 1 |
| Badawy, SZ | 1 |
| Elliott, LJ | 1 |
| Elbadawi, A | 1 |
| Marshall, LD | 1 |
| Gambrell, RD | 2 |
| MacDonald, PC | 1 |
| Grodin, JM | 1 |
| Edman, CD | 1 |
| Vellios, F | 1 |
| Siiteri, PK | 1 |
| Davidson, BJ | 1 |
| Schane, HP | 1 |
| Anzalone, AJ | 1 |
| Potts, GO | 1 |
| Hamada, H | 1 |
| Widholm, O | 1 |
| Vartiainen, E | 1 |
| Fraser, IS | 2 |
| Baird, DT | 2 |
| Michie, EA | 1 |
| Wide, L | 1 |
| Aronovich, AS | 1 |
| Manuilova, IA | 1 |
| Grudzień, M | 1 |
| Baudet, JH | 1 |
| Béguin, F | 1 |
| Keller, M | 1 |
| Stamm, O | 1 |
| Zarro, D | 1 |
| Giorgi, EP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation[NCT00563576] | 71 participants (Actual) | Interventional | 2007-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Bleeding and spotting were defined using World Health Organization criteria and measured through daily diaries given to participants and collected at the 3 and 6 month followup. In addition, a study staff member called participants weekly to collect the daily bleeding and spotting calendar for that week to optimize the accuracy of this information. (NCT00563576)
Timeframe: 3 months
| Intervention | days (Mean) |
|---|---|
| Femring | 16 |
| Depot Medroxyprogesterone Acetate (DMPA) Alone | 28 |
(NCT00563576)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Femring | 20 |
| Depot Medroxyprogesterone Acetate (DMPA) Alone | 16 |
(NCT00563576)
Timeframe: 6 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Femring | 13 |
| Depot Medroxyprogesterone Acetate (DMPA) Alone | 10 |
Acceptability was measured using questionnaires that assessed satisfaction of Femring and usage of the ring. This outcome was only measured among the intervention group of women who actually were randomized to use of Femring. Acceptability of the vaginal ring was high among those in the intervention group. (NCT00563576)
Timeframe: 3 months
| Intervention | participants (Number) |
|---|---|
| Femring | 84 |
1 review available for estrone and Hemorrhage, Uterine
| Article | Year |
|---|---|
[Hormone activity of various Brenner tumors].
Topics: Aged; Breast Neoplasms; Brenner Tumor; Estradiol; Estrone; Female; Humans; Neoplasm Metastasis; Neop | 1982 |
12 trials available for estrone and Hemorrhage, Uterine
| Article | Year |
|---|---|
Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch 40 and Estrapatch 60) with a twice week system.
Topics: Administration, Cutaneous; Adult; Aged; Drug Administration Schedule; Endometrium; Erythema; Estradi | 2005 |
Vaginal ring delivering estradiol and progesterone: a possible alternative to relieve climacteric symptoms.
Topics: Adult; Aged; Biopsy; Contraceptive Devices, Female; Dose-Response Relationship, Drug; Drug Delivery | 2005 |
Continuous combined piperazine oestrone sulphate and medroxyprogesterone acetate hormone replacement therapy--a study of bleeding pattern, endometrial response, serum lipid and bone density changes.
Topics: Administration, Oral; Bone Density; Drug Therapy, Combination; Endometrium; Estrogen Replacement The | 1995 |
Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial.
Topics: Blood Pressure; Drug Combinations; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated | 1996 |
Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Developmen
Topics: Adolescent; Adult; Contraceptive Agents, Female; Double-Blind Method; Estradiol Congeners; Estrogens | 1996 |
Randomized, double-blind, dose-ranging study of the endometrial effects of a vaginal progesterone gel in estrogen-treated postmenopausal women.
Topics: Adult; Aged; Biopsy; Dose-Response Relationship, Drug; Double-Blind Method; Endometrium; Estradiol; | 1997 |
Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
Topics: Administration, Cutaneous; Aged; Bone Density; Drug Therapy, Combination; Dydrogesterone; Endometriu | 1997 |
Bleeding pattern and endometrial changes during continuous combined hormone replacement therapy. The Ogen/Provera Study Group.
Topics: Adult; Biopsy, Needle; Double-Blind Method; Endometrium; Estrogen Replacement Therapy; Estrogens, Co | 1998 |
Piperazine oestrone sulphate and interrupted norethisterone: effects on the postmenopausal endometrium.
Topics: Administration, Oral; Endometrium; Estrone; Female; Hormone Replacement Therapy; Humans; Norethindro | 2000 |
Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
Topics: Adult; Animals; Bone Density; Bone Remodeling; CA-125 Antigen; Endometriosis; Estradiol; Estrogens, | 2001 |
Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women.
Topics: Double-Blind Method; Endometrial Hyperplasia; Equilin; Estrogen Replacement Therapy; Estrone; Female | 2000 |
The absorption of conjugated oestrogen and sodium oestrone sulphate from the vagina.
Topics: Aged; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause | 1974 |
25 other studies available for estrone and Hemorrhage, Uterine
| Article | Year |
|---|---|
Induction of uterine bleeding in amenorrhea with a single injection of precipitates of estrone and progesterone.
Topics: Amenorrhea; Estrogens; Estrone; Female; Gonadal Steroid Hormones; Hormones; Humans; Injections; Prog | 1948 |
Endometrial thickness and histopathologic findings in women with postmenopausal bleeding.
Topics: Aged; Androgens; Biopsy, Needle; Case-Control Studies; Dilatation and Curettage; Endometrium; Enzyme | 2003 |
[Use of intravenous estrone sulfate in hemostasis in functional uterine bleeding].
Topics: Estrogens; Estrone; Female; Hemostasis; Humans; Menorrhagia; Metrorrhagia; Uterine Hemorrhage | 1956 |
[ENDOCRINOLOGICAL STUDY ON THE PITUITARY-GONADAL SYSTEM, WITH SPECIAL REFERENCE TO CONDITIONS OF ANOVULATION].
Topics: Amenorrhea; Anovulation; Estradiol; Estrone; Female; Gonadotropins; Gonadotropins, Pituitary; Humans | 1963 |
[THE EVALUATION OF THE ESTROGENIC FUNCTION OF THE OVARY AFTER RADIUM THERAPY].
Topics: Cell Biology; Cytodiagnosis; Estrone; Female; Humans; Ovary; Radiotherapy; Radium; Uterine Hemorrhag | 1964 |
URINARY OESTROGEN EXCRETION IN THREATENED ABORTION.
Topics: Abortion, Induced; Abortion, Spontaneous; Abortion, Threatened; Diagnosis; Estradiol; Estriol; Estro | 1964 |
DRUGS FOR FUNCTIONAL UTERINE BLEEDING.
Topics: Contraceptive Agents; Contraceptives, Oral; Diethylstilbestrol; Dosage Forms; Drug Therapy; Dydroges | 1964 |
The polycystic ovary. VII. Intractable uterine bleeding and endometrial hyperplasia possibly related to an extraovarian source of oestrogen.
Topics: 17-Ketosteroids; Adrenal Glands; Adult; Androgens; Chromatography; Cysts; Endometrial Hyperplasia; E | 1967 |
Hormone levels in healthy post-menopausal women and in women with post-menopausal bleeding with or without endometrial carcinoma.
Topics: Adult; Aged; Androstenedione; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Hu | 1981 |
Plasma androstenedione and oestrone levels before and after the menopause. I. Glandular hyperplasia and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aging; Androstenedione; Endometrial Hyperplasia; Estrone; F | 1982 |
[Assessment of serum estrogen levels by RIA with HPLC during hormone replacement therapy].
Topics: Adult; Chromatography, High Pressure Liquid; Estradiol; Estrogen Replacement Therapy; Estrogens, Con | 1995 |
Plasma levels of oestrone and oestradiol-17beta in postmenopausal women.
Topics: Adult; Age Factors; Aged; Body Weight; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Femal | 1979 |
Postmenopausal bleeding.
Topics: Adenocarcinoma; Adrenal Glands; Androstenedione; Contraceptives, Oral; Dilatation and Curettage; End | 1977 |
Origin of estrogen in a postmenopausal woman with a nonendocrine tumor of the ovary and endometrial hyperplasia.
Topics: Androgens; Androstenedione; Castration; Cystadenoma; Endometrial Hyperplasia; Estrogens; Estrone; Fe | 1976 |
Urinary pregnandiol-3-glucuronide and estrone conjugates to creatinine ratios in early pregnancies complicated by vaginal bleeding.
Topics: Abortion, Threatened; Creatinine; Estrone; Female; Humans; Immunoenzyme Techniques; Pregnancy; Pregn | 1986 |
A model for the evaluation of estrogens: withdrawal bleeding in ovariectomized rhesus monkeys.
Topics: Administration, Oral; Animals; Castration; Diethylstilbestrol; Dose-Response Relationship, Drug; Est | 1972 |
The use of premarin, conjugated estrogens-equine to control. Functional uterine bleeding and the urinary estrogen metabolism after administration.
Topics: Administration, Oral; Adult; Estradiol; Estriol; Estrogens; Estrogens, Conjugated (USP); Estrone; Fe | 1971 |
Blood production and ovarian secretion rates of estradiol-17 beta and estrone in women with dysfunctional uterine bleeding.
Topics: Adult; Endometrium; Estradiol; Estrone; Female; Humans; Hyperplasia; Hysterectomy; Infusions, Parent | 1974 |
Pituitary gonadotropins and ovarian function in adolescent dysfunctional uterine bleeding.
Topics: Adult; Clomiphene; Estradiol; Estrogens; Estrone; Feedback; Female; Follicle Stimulating Hormone; Hu | 1973 |
Postmenopausal bleeding.
Topics: Adenocarcinoma; Adrenal Glands; Estradiol; Estrogens; Estrone; Ethinyl Estradiol; Female; Humans; Me | 1974 |
[Estrogen excretion during testosterone and progestagen therapy of dysfunctional climacteric hemorrhage].
Topics: Adult; Climacteric; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Middle Aged; Progestins; | 1969 |
[Urinary excretion of estrogens in women with bleeding during climacteric and in menopause].
Topics: Aged; Climacteric; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menarche; Menopause; Mens | 1970 |
[The painful syndromes of the cycle].
Topics: Adolescent; Adult; Cervix Mucus; Diuretics; Dysmenorrhea; Endometriosis; Estrone; Female; Humans; Hy | 1969 |
[Studies concerning the action mechanism of a retrosteroid, RO 4-8347].
Topics: 17-Ketosteroids; Adult; Amenorrhea; Dydrogesterone; Estradiol; Estriol; Estrone; Female; Humans; Inf | 1969 |
Steroids in cyst fluid from ovaries of normally menstruating women and of women with functional uterine bleeding.
Topics: Adult; Androgens; Chemical Phenomena; Chemistry; Cysts; Estradiol; Estrone; Female; Humans; Hydroxyp | 1965 |